PMGC (NASDAQ:ELAB) Stock Price Up 5.7% – Should You Buy?

PMGC Holdings Inc. (NASDAQ:ELABGet Free Report)’s share price shot up 5.7% during mid-day trading on Friday . The company traded as high as $1.56 and last traded at $1.12. 35,400,837 shares were traded during mid-day trading, an increase of 915% from the average session volume of 3,488,120 shares. The stock had previously closed at $1.06.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a research note on Friday, June 26th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

View Our Latest Report on PMGC

PMGC Stock Up 5.7%

The firm’s 50-day simple moving average is $1.59 and its 200 day simple moving average is $9.25. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.43 and a current ratio of 1.45. The stock has a market capitalization of $1.30 million, a P/E ratio of -0.01 and a beta of -0.23.

PMGC (NASDAQ:ELABGet Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($11.22) earnings per share for the quarter. The firm had revenue of $0.68 million during the quarter.

PMGC Company Profile

(Get Free Report)

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.

Further Reading

Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.